Dr. Kouros Nourimahdavi, MD, MS

Dr. Nourimahdavi practices at Peter Morton UCLA Medical Building in Los Angeles, California.

Dr. Nourimahdavi's NPI, 1326225137, was assigned on January 23, 2008. Dr. Nourimahdavi graduated from Isfahan University of Medical Sciences in 1989. Dr. Nourimahdavi holds California license A102448.

Dr. Nourimahdavi's primary practice is Peter Morton UCLA Medical Building, at 200 Medical Plz, Los Angeles, CA 90024 in Los Angeles County. The practice phone is (310) 794-9206.

Dr. Nourimahdavi's primary practice is Peter Morton UCLA Medical Building in Los Angeles, California. Dr. Nourimahdavi is also affiliated with Ronald Reagan UCLA Medical Center. The medical group on file is Harbor-UCLA Medical Center. Dmand AI also links Dr. Nourimahdavi to 3 more group practices and clinics and 3 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Nourimahdavi practices, 4 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Nourimahdavi's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Nourimahdavi is board certified in ophthalmology by the American Board of Ophthalmology. Dr. Nourimahdavi is licensed in California.

Dmand AI lists age-related macular degeneration, cataract, cataract surgery with lens implant, conjunctivitis, dry eye, eye infection or inflammation, eyelid inflammation and glaucoma among the conditions Dr. Nourimahdavi treats.

CMS data shows 2,982 Medicare services from Dr. Nourimahdavi across 16 procedure codes in 2024, for 1,405 Medicare patients. Medicare paid $335,840 for them.

CMS counts 1,405 Medicare patients who saw Dr. Nourimahdavi in 2024. The largest group is 75 to 84, with 614 patients. 75% of them have high cholesterol, and 73% have high blood pressure. 21% are also on Medicaid. Their average risk score is 1.31, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Nourimahdavi's median patient age at 76, with 55% women.

In 2024, Dr. Nourimahdavi wrote 6,482 Medicare Part D claims for 1,200 patients. 53% of them were for generic drugs. CMS names the drug for 6,387 of them, across 34 drugs with 11 or more claims each, at $997,654 in total drug cost. In 2023, CMS named 5,633 claims across 31 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Dr. Nourimahdavi for performance year 2024, reported as part of a group. Dr. Nourimahdavi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 145 procedures of cataract surgery by Dr. Nourimahdavi, more than 79% of the clinicians it reports for that procedure.

Dmand AI links Dr. Nourimahdavi to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Disease Progression and Glaucoma, Open-Angle.

CMS Open Payments shows 35 general payments to Dr. Nourimahdavi from 11 drug and device companies from 2016 to 2025. Grants make up the largest share, 73% of the total. Alcon Research Ltd paid the most, $200,000.

Dmand AI lists 2 awards for Dr. Nourimahdavi, most recently Secretariat Award in 2019.

Dr. Nourimahdavi graduated from Isfahan University of Medical Sciences in 1989. Dr. Nourimahdavi is a member of AAO, American Glaucoma Society and Association for Research in Vision and Ophthalmology.

Dr. Nourimahdavi is in network with 14 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.